These authors aimed to quantify the 20-year survival and clinical outcomes for a cemented keeled ultra-high-molecular weight all-polyethylene, flat backed glenoid component and a cemented stemmed Aequalis humeral component.
An individual surgeon performed 44 shoulder replacements in 40 patients (age at surgery 68.5yrs, 82.5% female. The indication for surgery was rheumatoid arthritis in 14 (35%) patients and
68 osteoarthritis in 26 (65%).
29 patients (72%) were deceased with the prostheses in place at the time of the latest review. Of the 11 remaining patients (12 arthroplasties), three had undergone revision surgery, two suffered from severe dementia leaving only six patients (seven arthroplasties) who completed the clinical review.
Survival with all-cause revision as an end point was reported to be 94.6% at 10 years, 90.1% at 15 years and 84.1% at 20 years. Glenoid loosening was seen in all patients who survived to 20 years follow-up.
Survival of rotator cuff integrity was reported to be 16.8% at 20 years.
Radiographic loosening of components was reported to be 0/39 (0%) humeral implants and 20/39 (51.2%) glenoid implants. Glenoid loosening was first identified on radiographs at an average of 11.4 years post-surgery.
Comment: This study demonstrates that patients having shoulder arthroplasties performed 20 years ago with a flat-backed, keeled component are at risk for glenoid component loosening and cuff failure. However, only 7% (3/44) came to surgical revision. 72% of the patients died with their prosthesis in place.